首页> 外国专利> METHOD FOR PREDICTION OF EARLY RELAPSE IN PATIENTS WITH HAEMOBLASTOSES FOLLOWING AUTOLOGOUS STEM HAEMOPOIETIC CELL TRANSPLANTATION

METHOD FOR PREDICTION OF EARLY RELAPSE IN PATIENTS WITH HAEMOBLASTOSES FOLLOWING AUTOLOGOUS STEM HAEMOPOIETIC CELL TRANSPLANTATION

机译:自体干造血细胞移植后预测具有血成纤维细胞的患者的早期缓解的方法

摘要

FIELD: medicine.;SUBSTANCE: relative CD4+FOXP3+ T-cell count in peripheral blood of the patients suffering with haemoblastoses is determined after autologous stem haemopoietic cell transplantation in a period of the lymphocyte recovery to 500 cell/mcl. If observing an increase of the CD4+FOXP3+T-raeTOK count more than 9.1%, the development of an early relapse in the post-transplantation period.;EFFECT: using the given method enables grouping the patients suffering haemoblastoses as suffering a high-risk of the development of an early relapse of the primary disease following autologous stem haemopoietic cell transplantation and in need of the additional courses of the radiation therapy and chemotherapy for the purpose of improving the efficacy of autologous stem haemopoietic cell transplantation.;4 ex
机译:领域:医学。;研究对象:自体干造血细胞移植一段时间后,测定成血糖患者的外周血中相对CD4 + FOXP3 + T细胞计数淋巴细胞恢复至> 500细胞/ mcl。如果观察到CD4 + FOXP3 + T-raeTOK计数增加9.1%以上,则表明移植后早期复发。给定的方法能够将患有成血成糖的患者归为自体干造血细胞移植后原发疾病的早期复发发展高危患者,并且需要进行其他放射治疗和化学疗法以改善疾病自体造血干细胞移植的功效。; 4 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号